Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Post by juicyjmillson Jul 06, 2020 2:10am

361 Views

Post# 31227144

I'm curious, for those of you that know....

When the market crashes in the next few weeks/months, what are your thoughts on holding ATE/stocks in general as that takes place?

Personally I've moved some money into companies and assets that have partnered with digital currencies (eg. moneygram and ripple) to hedge against the devaluation of the dollar.

But as for this stock, I have followed, supported, and believed in the great potential in Wallace' science for years and I believe the real value of this science is yet to be unleashed. The only unknown is what will happen to the valuation of currency and how will that impact shareholders in the equities markets.

Bullboard Posts

Cross border trading in Canada and Australia